InsiderDB

Lobbying disclosures · Lobbying report

COR: second_quarter 2026 lobbying report

Issues related to corporate taxation. Issues related to reimbursement and Medicare Part B. Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to the role and value of community specialty physicians. Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to drug shortages and national stockpiles at the U. S. Department of War.

Follow COR
Became public
Jul 20, 2026, 4:54 PM EDT
Event / period date
Not stated
Collected
Nov 10, 2026, 1:49 PM EST

Why this is connected

Legal-name match: CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) is Cencora, Inc. (https://www.sec.gov/Archives/edgar/data/1140859/), differing only in punctuation, "the" or suffix spelling (Corp/Corporation).

Reported lobbying amounts

Income: $60,000.00

These are different reporting measures. They are not added together or treated as spending on one particular bill.

Source evidence

Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/2f4c0bdd-825f-47bc-abad-2874f0c6932c/","filing_uuid":"2f4c0bdd-825f-47bc-abad-2874f0c6932c","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/2f4c0bdd-825f-47bc-abad-2874f0c6932c/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Teresa Schofield","dt_posted":"2026-07-20T16:54:59-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"607 - 14th Street NW","registrant_address_2":"Suite 750","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":320918,"url":"https://lda.gov/api/v1/registrants/320918/","house_registrant_id":39554,"name":"KOUNTOUPES DENHAM CARR & REID, LLC","description":"Federal lobbying and consulting services","address_1":"607 - 14th Street NW","address_2":"Suite 750","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"NANCY HARPER MARLOW","contact_telephone":"+1 202-803-4585","dt_updated":"2026-07-22T14:29:32.717701-04:00"},"client":{"id":186716,"url":"https://lda.gov/api/v1/clients/186716/","client_id":1005371,"name":"CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION)","general_description":"Pharmaceutical Distributor","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2018-04-18"},"lobbying_activities":[{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to corporate taxation.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":45200,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"DENHAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72966,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"HECHAVARRIA","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to reimbursement and Medicare Part B.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":10646,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":"HERSHEY","last_name":"CARR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to the role and value of community specialty physicians.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":45200,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"DENHAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":10646,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":"HERSHEY","last_name":"CARR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141462,"prefix":"ms","prefix_display":"MS.","first_name":"MARY","nickname":null,"middle_name":"DEE","last_name":"BEAL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144880,"prefix":null,"prefix_display":null,"first_name":"LESLIE","nickname":null,"middle_name":null,"last_name":"ZELENKO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":59326,"prefix":"ms","prefix_display":"MS.","first_name":"MARY","nickname":null,"middle_name":"R \"RANDI\"","last_name":"REID","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72966,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"HECHAVARRIA","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":45200,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"DENHAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":10646,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":"HERSHEY","last_name":"CARR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141462,"prefix":"ms","prefix_display":"MS.","first_name":"MARY","nickname":null,"middle_name":"DEE","last_name":"BEAL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144880,"prefix":null,"prefix_display":null,"first_name":"LESLIE","nickname":null,"middle_name":null,"last_name":"ZELENKO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72966,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"HECHAVARRIA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":59326,"prefix":"ms","prefix_display":"MS.","first_name":"MARY","nickname":null,"middle_name":"R \"RANDI\"","last_name":"REID","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Issues related to drug shortages and national stockpiles at the U. S. Department of War.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":45200,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"DENHAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}

Congressional trading in COR

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.